Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 8
Original Research
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,178 | Dovepress* | 6,543+ | 1,177 | 7,720 | |
| PubMed Central* | 635 | 240 | 875 | ||
| Totals | 7,178 | 1,417 | 8,595 | ||
| *Since 6 November 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar